English

BIOLIFE SOLUTIONS INC

EDGAR

BLFS Quarterly report (10-Q) · filed 2026-08-06

274 filing records in this dataset, filed from 1995-05-15 to 2026-08-06. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 24 million USD 2026-06-30 Source
Exact value

23997000 USD
Long-term debt including current maturities: 0 USD 2026-06-30 Source
Exact value

0 USD
Shares outstanding: 48.9 million shares 2026-06-30 Source
Exact value

48889090 shares

Reported share-count change

2.18% · 1.04 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

47845838 shares · 2025-06-30· Source
48889090 shares · 2026-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-06.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 10 of 11 periods available· newest 2025-12-31
Net income: 10 of 11 periods available· newest 2025-12-31
Operating cash flow: 10 of 11 periods available· newest 2025-12-31
Capital expenditure: 10 of 11 periods available· newest 2025-12-31
Total assets: 10 of 11 periods available· newest 2025-12-31
Total liabilities: 10 of 11 periods available· newest 2025-12-31
Current assets: 10 of 11 periods available· newest 2025-12-31
Current liabilities: 10 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 8 of 11 periods available· newest 2025-12-31
Shares outstanding: 10 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 15.59 million

Prior period

−USD 20.18 million

2024-01-01 – 2024-12-31
Current period

−USD 4.6 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-4595000 − -20184000 = 15589000 USD

-20184000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-4595000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIOLIFE SOLUTIONS INC · 2025-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Year-over-year change in Net income: 15589000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -4595000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#959743 Filing: 000162828026012294 Input fundies:NetIncome: -20184000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#960515 Filing: 000162828026012294
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+138.6%

Prior period

USD 8.43 million

2024-01-01 – 2024-12-31
Current period

USD 20.12 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

20115000 − 8431000 = 11684000 USD

8431000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
20115000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIOLIFE SOLUTIONS INC · 2025-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Year-over-year change in Operating cash flow: 11684000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 20115000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1010807 Filing: 000162828026012294 Input fundies:OperatingCashFlow: 8431000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1011454 Filing: 000162828026012294
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+193.7%

Prior period

USD 3.23 million

2024-01-01 – 2024-12-31
Current period

USD 9.48 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

9478000 − 3227000 = 6251000 USD

3227000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
9478000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BIOLIFE SOLUTIONS INC · 2025-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Year-over-year change in Capital expenditure: 6251000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 9478000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1014026 Filing: 000162828026012294 Input fundies:CapitalExpenditure: 3227000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1014616 Filing: 000162828026012294
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 4.21 million Exact value Exact value: -4213936 USD 2015-01-01 – 2015-12-31: -4213936 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOLIFE SOLUTIONS INC · 2015-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Net Income: -4213936 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4213936 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420417014799/blfs-20161231.xml#106748 Filing: 000114420417014799 The citation records this snapshot. The page link may show a newer release later.	−USD 4.97 million Exact value Exact value: -4973861 USD 2015-01-01 – 2015-12-31: -4973861 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOLIFE SOLUTIONS INC · 2015-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Operating Cash Flow: -4973861 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4973861 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420417014799/blfs-20161231.xml#115876 Filing: 000114420417014799 The citation records this snapshot. The page link may show a newer release later.	USD 134,012 Exact value Exact value: 134012 USD 2015-01-01 – 2015-12-31: 134012 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOLIFE SOLUTIONS INC · 2015-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Capital Expenditure: 134012 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 134012 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420417014799/blfs-20161231.xml#117438 Filing: 000114420417014799 The citation records this snapshot. The page link may show a newer release later.	−USD 5.11 million Calculation and evidence -4973861 − 134012 USD Exact free cash flow: -5107873 USD 2015-01-01 – 2015-12-31: -4973861 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 134012 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOLIFE SOLUTIONS INC · 2015-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Free cash flow: -5107873 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4973861 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420417014799/blfs-20161231.xml#115876 Filing: 000114420417014799 Input fundies:CapitalExpenditure: 134012 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420417014799/blfs-20161231.xml#117438 Filing: 000114420417014799 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 6.88 million Exact value Exact value: -6875446 USD 2016-01-01 – 2016-12-31: -6875446 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOLIFE SOLUTIONS INC · 2016-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Net Income: -6875446 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6875446 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420418013727/blfs-20171231.xml#660303 Filing: 000114420418013727 The citation records this snapshot. The page link may show a newer release later.	−USD 4.33 million Exact value Exact value: -4326991 USD 2016-01-01 – 2016-12-31: -4326991 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOLIFE SOLUTIONS INC · 2016-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Operating Cash Flow: -4326991 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4326991 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420418013727/blfs-20171231.xml#831361 Filing: 000114420418013727 The citation records this snapshot. The page link may show a newer release later.	USD 143,533 Exact value Exact value: 143533 USD 2016-01-01 – 2016-12-31: 143533 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOLIFE SOLUTIONS INC · 2016-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Capital Expenditure: 143533 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 143533 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420418013727/blfs-20171231.xml#662696 Filing: 000114420418013727 The citation records this snapshot. The page link may show a newer release later.	−USD 4.47 million Calculation and evidence -4326991 − 143533 USD Exact free cash flow: -4470524 USD 2016-01-01 – 2016-12-31: -4326991 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 143533 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOLIFE SOLUTIONS INC · 2016-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Free cash flow: -4470524 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4326991 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420418013727/blfs-20171231.xml#831361 Filing: 000114420418013727 Input fundies:CapitalExpenditure: 143533 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420418013727/blfs-20171231.xml#662696 Filing: 000114420418013727 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 2.52 million Exact value Exact value: -2515106 USD 2017-01-01 – 2017-12-31: -2515106 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOLIFE SOLUTIONS INC · 2017-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Net Income: -2515106 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2515106 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420418013727/blfs-20171231.xml#660164 Filing: 000114420418013727 The citation records this snapshot. The page link may show a newer release later.	USD 605,122 Exact value Exact value: 605122 USD 2017-01-01 – 2017-12-31: 605122 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOLIFE SOLUTIONS INC · 2017-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Operating Cash Flow: 605122 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 605122 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420418013727/blfs-20171231.xml#831166 Filing: 000114420418013727 The citation records this snapshot. The page link may show a newer release later.	USD 143,767 Exact value Exact value: 143767 USD 2017-01-01 – 2017-12-31: 143767 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOLIFE SOLUTIONS INC · 2017-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Capital Expenditure: 143767 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 143767 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420418013727/blfs-20171231.xml#662501 Filing: 000114420418013727 The citation records this snapshot. The page link may show a newer release later.	USD 461,355 Calculation and evidence 605122 − 143767 USD Exact free cash flow: 461355 USD 2017-01-01 – 2017-12-31: 605122 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 143767 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOLIFE SOLUTIONS INC · 2017-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Free cash flow: 461355 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 605122 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420418013727/blfs-20171231.xml#831166 Filing: 000114420418013727 Input fundies:CapitalExpenditure: 143767 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000114420418013727/blfs-20171231.xml#662501 Filing: 000114420418013727 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 1.66 million Exact value Exact value: -1657000 USD 2019-01-01 – 2019-12-31: -1657000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOLIFE SOLUTIONS INC · 2019-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Net Income: -1657000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1657000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000143774922007869/bioli20211231_10k.htm#1569445 Filing: 000143774922007869 The citation records this snapshot. The page link may show a newer release later.	USD 1.21 million Exact value Exact value: 1213000 USD 2019-01-01 – 2019-12-31: 1213000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOLIFE SOLUTIONS INC · 2019-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Operating Cash Flow: 1213000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1213000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000143774922007869/bioli20211231_10k.htm#1345625 Filing: 000143774922007869 The citation records this snapshot. The page link may show a newer release later.	USD 675,000 Exact value Exact value: 675000 USD 2019-01-01 – 2019-12-31: 675000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOLIFE SOLUTIONS INC · 2019-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Capital Expenditure: 675000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 675000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000143774922007869/bioli20211231_10k.htm#1375593 Filing: 000143774922007869 The citation records this snapshot. The page link may show a newer release later.	USD 538,000 Calculation and evidence 1213000 − 675000 USD Exact free cash flow: 538000 USD 2019-01-01 – 2019-12-31: 1213000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 675000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOLIFE SOLUTIONS INC · 2019-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Free cash flow: 538000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1213000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000143774922007869/bioli20211231_10k.htm#1345625 Filing: 000143774922007869 Input fundies:CapitalExpenditure: 675000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000143774922007869/bioli20211231_10k.htm#1375593 Filing: 000143774922007869 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 1.98 million Exact value Exact value: 1983000 USD 2020-01-01 – 2020-12-31: 1983000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOLIFE SOLUTIONS INC · 2020-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Net Income: 1983000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1983000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000143774923008875/bioli20221231_10k.htm#1743433 Filing: 000143774923008875 The citation records this snapshot. The page link may show a newer release later.	USD 6.65 million Exact value Exact value: 6645000 USD 2020-01-01 – 2020-12-31: 6645000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOLIFE SOLUTIONS INC · 2020-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Operating Cash Flow: 6645000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6645000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000143774923008875/bioli20221231_10k.htm#1300198 Filing: 000143774923008875 The citation records this snapshot. The page link may show a newer release later.	USD 1.96 million Exact value Exact value: 1961000 USD 2020-01-01 – 2020-12-31: 1961000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOLIFE SOLUTIONS INC · 2020-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Capital Expenditure: 1961000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1961000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000143774923008875/bioli20221231_10k.htm#1313294 Filing: 000143774923008875 The citation records this snapshot. The page link may show a newer release later.	USD 4.68 million Calculation and evidence 6645000 − 1961000 USD Exact free cash flow: 4684000 USD 2020-01-01 – 2020-12-31: 6645000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 1961000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOLIFE SOLUTIONS INC · 2020-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Free cash flow: 4684000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6645000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000143774923008875/bioli20221231_10k.htm#1300198 Filing: 000143774923008875 Input fundies:CapitalExpenditure: 1961000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000143774923008875/bioli20221231_10k.htm#1313294 Filing: 000143774923008875 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 8.91 million Exact value Exact value: -8908000 USD 2021-01-01 – 2021-12-31: -8908000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOLIFE SOLUTIONS INC · 2021-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Net Income: -8908000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8908000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828024008061/blfs-20231231.htm#1266012 Filing: 000162828024008061 The citation records this snapshot. The page link may show a newer release later.	−USD 4.59 million Exact value Exact value: -4593000 USD 2021-01-01 – 2021-12-31: -4593000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOLIFE SOLUTIONS INC · 2021-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Operating Cash Flow: -4593000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4593000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828024008061/blfs-20231231.htm#1125290 Filing: 000162828024008061 The citation records this snapshot. The page link may show a newer release later.	USD 8.39 million Exact value Exact value: 8385000 USD 2021-01-01 – 2021-12-31: 8385000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOLIFE SOLUTIONS INC · 2021-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Capital Expenditure: 8385000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8385000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828024008061/blfs-20231231.htm#1130439 Filing: 000162828024008061 The citation records this snapshot. The page link may show a newer release later.	−USD 12.98 million Calculation and evidence -4593000 − 8385000 USD Exact free cash flow: -12978000 USD 2021-01-01 – 2021-12-31: -4593000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 8385000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOLIFE SOLUTIONS INC · 2021-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Free cash flow: -12978000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4593000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828024008061/blfs-20231231.htm#1125290 Filing: 000162828024008061 Input fundies:CapitalExpenditure: 8385000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828024008061/blfs-20231231.htm#1130439 Filing: 000162828024008061 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 139.81 million Exact value Exact value: -139805000 USD 2022-01-01 – 2022-12-31: -139805000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOLIFE SOLUTIONS INC · 2022-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Net Income: -139805000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -139805000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828025009511/blfs-20241231.htm#1007912 Filing: 000162828025009511 The citation records this snapshot. The page link may show a newer release later.	−USD 8.49 million Exact value Exact value: -8488000 USD 2022-01-01 – 2022-12-31: -8488000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOLIFE SOLUTIONS INC · 2022-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Operating Cash Flow: -8488000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8488000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828025009511/blfs-20241231.htm#1059021 Filing: 000162828025009511 The citation records this snapshot. The page link may show a newer release later.	USD 10.39 million Exact value Exact value: 10385000 USD 2022-01-01 – 2022-12-31: 10385000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOLIFE SOLUTIONS INC · 2022-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Capital Expenditure: 10385000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10385000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828025009511/blfs-20241231.htm#1062152 Filing: 000162828025009511 The citation records this snapshot. The page link may show a newer release later.	−USD 18.87 million Calculation and evidence -8488000 − 10385000 USD Exact free cash flow: -18873000 USD 2022-01-01 – 2022-12-31: -8488000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 10385000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOLIFE SOLUTIONS INC · 2022-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Free cash flow: -18873000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8488000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828025009511/blfs-20241231.htm#1059021 Filing: 000162828025009511 Input fundies:CapitalExpenditure: 10385000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828025009511/blfs-20241231.htm#1062152 Filing: 000162828025009511 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 68 million Exact value Exact value: -68002000 USD 2023-01-01 – 2023-12-31: -68002000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOLIFE SOLUTIONS INC · 2023-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Net Income: -68002000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -68002000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#961288 Filing: 000162828026012294 The citation records this snapshot. The page link may show a newer release later.	−USD 12.5 million Exact value Exact value: -12498000 USD 2023-01-01 – 2023-12-31: -12498000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOLIFE SOLUTIONS INC · 2023-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Operating Cash Flow: -12498000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12498000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1012101 Filing: 000162828026012294 The citation records this snapshot. The page link may show a newer release later.	USD 6.38 million Exact value Exact value: 6381000 USD 2023-01-01 – 2023-12-31: 6381000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOLIFE SOLUTIONS INC · 2023-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Capital Expenditure: 6381000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6381000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1015206 Filing: 000162828026012294 The citation records this snapshot. The page link may show a newer release later.	−USD 18.88 million Calculation and evidence -12498000 − 6381000 USD Exact free cash flow: -18879000 USD 2023-01-01 – 2023-12-31: -12498000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 6381000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOLIFE SOLUTIONS INC · 2023-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Free cash flow: -18879000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12498000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1012101 Filing: 000162828026012294 Input fundies:CapitalExpenditure: 6381000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1015206 Filing: 000162828026012294 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 20.18 million Exact value Exact value: -20184000 USD 2024-01-01 – 2024-12-31: -20184000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOLIFE SOLUTIONS INC · 2024-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Net Income: -20184000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20184000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#960515 Filing: 000162828026012294 The citation records this snapshot. The page link may show a newer release later.	USD 8.43 million Exact value Exact value: 8431000 USD 2024-01-01 – 2024-12-31: 8431000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOLIFE SOLUTIONS INC · 2024-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Operating Cash Flow: 8431000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8431000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1011454 Filing: 000162828026012294 The citation records this snapshot. The page link may show a newer release later.	USD 3.23 million Exact value Exact value: 3227000 USD 2024-01-01 – 2024-12-31: 3227000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOLIFE SOLUTIONS INC · 2024-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Capital Expenditure: 3227000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3227000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1014616 Filing: 000162828026012294 The citation records this snapshot. The page link may show a newer release later.	USD 5.2 million Calculation and evidence 8431000 − 3227000 USD Exact free cash flow: 5204000 USD 2024-01-01 – 2024-12-31: 8431000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 3227000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOLIFE SOLUTIONS INC · 2024-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Free cash flow: 5204000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8431000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1011454 Filing: 000162828026012294 Input fundies:CapitalExpenditure: 3227000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1014616 Filing: 000162828026012294 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 4.6 million Exact value Exact value: -4595000 USD 2025-01-01 – 2025-12-31: -4595000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOLIFE SOLUTIONS INC · 2025-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Net Income: -4595000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4595000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#959743 Filing: 000162828026012294 The citation records this snapshot. The page link may show a newer release later.	USD 20.12 million Exact value Exact value: 20115000 USD 2025-01-01 – 2025-12-31: 20115000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOLIFE SOLUTIONS INC · 2025-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Operating Cash Flow: 20115000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 20115000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1010807 Filing: 000162828026012294 The citation records this snapshot. The page link may show a newer release later.	USD 9.48 million Exact value Exact value: 9478000 USD 2025-01-01 – 2025-12-31: 9478000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOLIFE SOLUTIONS INC · 2025-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Capital Expenditure: 9478000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9478000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1014026 Filing: 000162828026012294 The citation records this snapshot. The page link may show a newer release later.	USD 10.64 million Calculation and evidence 20115000 − 9478000 USD Exact free cash flow: 10637000 USD 2025-01-01 – 2025-12-31: 20115000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 9478000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOLIFE SOLUTIONS INC · 2025-12-31 BIOLIFE SOLUTIONS INC (edgar:834365) Free cash flow: 10637000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:10:29Z Snapshot: 23cf2845f533a2bf9e1888cecb2e313bd2419f9f49145053a9c91eb32d617b21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/834365?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 20115000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1010807 Filing: 000162828026012294 Input fundies:CapitalExpenditure: 9478000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm#1014026 Filing: 000162828026012294 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

274 filings · 4,517 latest values · 4,514 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000834365, 834365, BLFS, blfs, edgar:834365

Also known as BIOLIFE SOLUTIONS INC, BioLife Solutions, Inc, BioLife Solutions, Inc., CRYOMEDICAL SCIENCES INC

BIOLIFE SOLUTIONS INC

Reported share-count change

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation